GlassScriptPhysician profile
Lucie Capek
NPI 1053351726
$20,084.07
in general payments reported to CMS, 2019-2025
8 companies · $4,943 in 2025
The $4,943 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $103 · 2021: $3,512 · 2022: $2,908 · 2023: $4,491 · 2024: $3,632 · 2025: $4,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $1,110 · Education: $53.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,903.90 |
| Food and Beverage | $1,109.72 |
| Education | $53.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12,008.49 | 2022-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $7,397.08 | 2019-2023 | |
| Merz North America, INC. | $495.93 | 2019-2025 | Xeomin |
| Medical Device Business Services, INC. | $95.39 | 2019 | |
| Revance Therapeutics, INC. | $34.53 | 2025 | Daxxify |
| Musculoskeletal Transplant Foundation INC. | $20.16 | 2024 | |
| Ethicon US, LLC | $19.18 | 2023 | Harmonic |
| Galderma Laboratories, L.P. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucie Capek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.